Background
QI in primary care practice
Cardiovascular disease and the ABCS
Methods/design
Study design
Description | Level | Source of data | Type of data | Frequency | |
---|---|---|---|---|---|
Cooperative grant proposals | Cooperative’s initial plan for implementation | Cooperative-level | Collected by ESCALATES team with Cooperatives assistance | Qualitative | Pre-grant award |
Other documents | Documents Cooperative’s develop (ex: recruitment materials, PF curricula, etc.) | Cooperative-level | Collected by ESCALATES team with Cooperatives assistance | Qualitative | Throughout study period |
Online diaries | Online journal; approximately 5-13 people per Cooperative; document implementation experiences | Cooperative-level | Online, interactive communication platform | Qualitative | Post 2x mo.; Start-up to post-implementation |
Cooperative site visits | To observe and understand how interventions are implemented | Cooperative-level | Fieldnotes | Qualitative | Annually years 2 and 3 |
Sustainability site visits | To understand how/which parts of the D&I infrastructure is sustained beyond the life of the grant | Cooperative-level | Fieldnotes | Qualitative | Year 4 |
Semi-structured interviews | To understand barriers/facilitators of specific aspects of implementation; experience with intervention; mechanisms of change | Cooperative-level | Interviews with Cooperative key stakeholders | Qualitative | Annually with 5-8 people or as needed |
Clinical quality measures (ABCS) | Proportion of patients meeting ABCS and data source (e.g. EHR, chart review) | Aggregated by Practice | Medical Record (EHR extraction/chart reviews); collected by Cooperatives; shared with ESCALATES | Quantitative | Baseline through end of study; Quarterly |
Stratified ABCS measures | Proportion of patients stratified by gender, age, race, ethnicity, insurance type meeting ABCS | Aggregated by practice | Medical record (EHR extraction); collected by Cooperatives; shared with ESCALATES | Quantitative | Baseline through end of study; Quarterly |
Practice survey | Practice capacity (CPCQ), EHR adoption, practice demographics (internal and external characteristics) | Practice-level | Survey (online/paper); completed by office manager or designated clinic leader; collected by Cooperatives; shared with ESCALATES | Quantitative | Baseline, post-intervention, 6 m follow up |
Practice member survey | Practice capacity (AR), focus on patients’ needs and resources, practice readiness to change, burnout, clinician attitudes towards new guidelines | Aggregated by Practice | Survey (online/paper) completed by a majority of practice members (target > 70 %); collected by Cooperatives; shared with ESCALATES | Quantitative | Baseline, post-intervention, 6 m follow up |
External support intervention tracking | Type of external support provided, date of contact, mode of contact, duration of contact, practice engagement assessment | Practice-level | Collected by Cooperatives; shared with ESCALATES | Quantitative | Regular intervals; TBD by grantees and evaluation |
Practice implementation intervention tracking | Strategies in place to improve ABCS, assessment of the extent to which strategies are implemented | Practice-level | Collected by Cooperatives; shared with ESCALATES | Quantitative | At least baseline and post-intervention |
Practice site visits | To observe and understand how interventions are implemented | Cooperative-level | Fieldnotes | Qualitative | 60 practice site visits across years 2 and 3 |
Patient pathways | To observe patients exposure to/experience with intervention | Practice-level | Observation by evaluation team during site visits | Qualitative | Observe five–ten patient visits at each practice visit |
Context assessment | To understand the contextual factors of implementation | Cooperative-level | Interviews with Cooperative key stakeholders | Qualitative | Annually with two–three people or as needed |
- Multi-level focus on Cooperatives and practices - Longitudinal data collection over three years - Baseline and quarterly data collection on cardiovascular measures - Collection of practice capacity outcome at baseline, and two time points post-intervention - Extensive qualitative data collection through document review, interviews, online diaries, and observation - Detailed external support and practice implementation tracking - Measurement of implementation science conceptual markers - Assessments of change in small, medium-sized family medicine practices - Formative and summative evaluation assessments - Mixed methods integration of the quantitative and qualitative results |
Study setting and population
Evaluation framework
Data collection
Cooperative-level data collection
Collection of documents
Online diaries
Site visits
Cooperative semi-structured interviews
Practice-level data collection
ABCS data
Measure | Description (CMS e-quality measure, National Quality Forum measure) | Source of data |
---|---|---|
Proportion of patients in a practice at risk for CVD receiving guideline-concordant care (ABCS) Data will be reported for the practice overall, and stratified by gender, race, ethnicity, age, and insurance type. | Patients within each practice who are: 18 years of age and older who were discharged alive for acute myocardial infarction, coronary artery bypass graft or percutaneous coronary interventions in the 12 months prior to the measurement period, or who had an active diagnosis of ischemic vascular disease during the measurement period, and who had documentation of use of aspirin or another antithrombotic during the measurement period (Aspirin, A, CMS164v4, NQF0068) | Medical Record (EHR extraction/chart reviews); collected by Cooperatives; shared with ESCALATES |
18-85 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled (<140/90 mmHg) during the measurement period (Blood Pressure, B, CMS165v4, NQF0018) | ||
High-risk adult patients aged > = 21 years who were previously diagnosed with or currently have an active diagnosis of clinical atherosclerotic cardiovascular disease; OR adult patients aged > =21 years with a fasting or direct Low-Density Lipoprotein Cholesterol (LDL-C) level > = 190 mg/dL; OR patients aged 40-75 years with a diagnosis of diabetes with a fasting or direct LDL-C level of 70-189 mg/dL; who were prescribed or are already on statin medication therapy during the measurement year (Cholesterol Management, C, CMS347) | ||
18 years and older, who were screened for tobacco use 1or more times within 24 months AND who received cessation counseling intervention if identified as a tobacco user (Smoking, S, CMS138v4, NQF0028) |